Partial block by Riluzole of muscle sodium channels in Myotubes from amyotrophic lateral sclerosis patients

Neurology Research International

Volumn 2014, Issue , 2014, Pages

  Deflorio, Cristina ^a   Onesti, Emanuela ^b   Lauro, Clotilde ^a   Tartaglia, Giorgio ^b   Giovannelli, Aldo ^c   Limatola, Cristina ^a,d,e   Inghilleri, Maurizio ^b   Grassi, Francesca ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF L'AQUILA   (Italy)

^d ISTITUTO ITALIANO DI TECNOLOGIA   (Italy)

^e IRCCS NEUROMED   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

RILUZOLE; VOLTAGE GATED SODIUM CHANNEL;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CLINICAL ARTICLE; DISEASE COURSE; DISEASE DURATION; DRUG EFFECT; ELECTROMYOGRAPHY; FEMALE; FIBRILLATION POTENTIAL; HUMAN; HUMAN TISSUE; MALE; MEMBRANE POTENTIAL; MIDDLE AGED; MUSCLE ACTION POTENTIAL; MUSCLE BIOPSY; MUSCLE INNERVATION; MUSCLE STRENGTH; MYOTUBE; SODIUM CURRENT; STEADY STATE; TIBIALIS ANTERIOR MUSCLE; TREATMENT DURATION; WHOLE CELL PATCH CLAMP;

EID: 84919784499     PISSN: 20901852     EISSN: 20901860     Source Type: Journal    
DOI: 10.1155/2014/946073     Document Type: Article

References (31)

1. M. de Carvalho, R. Dengler, A. Eisen et al., "Electrodiagnostic criteria for diagnosis of ALS," Clinical Neurophysiology, vol. 119, no. 3, pp. 497-503, 2008.
2. M. Inghilleri and E. Iacovelli, "Clinical neurophysiology in ALS," Archives Italiennes de Biologie, vol. 149, no. 1, pp. 57-63, 2011.
3. T. Sekiguchi, T. Kanouchi, K. Shibuya et al., "Spreading of amyotrophic lateral sclerosis lesions-multifocal hits and local propagation" Journal of Neurology, Neurosurgery & Psychiatry, vol. 85, no. 1, pp. 85-91, 2014.
4. D. Purves and B. Sakmann, "Membrane properties underlying spontaneous activity of denervated muscle fibres," The Journal of Physiology, vol. 239, no. 1, pp. 125-153, 1974.
5. K. Sekiguchi, F. Kanda, S. Mitsui, N. Kohara, and K. Chihara, "Fibrillation potentials of denervated rat skeletal muscle are associated with expression of cardiac-type voltage-gated sodium channel isoform Nav1. 5," Clinical Neurophysiology, vol. 123, no. 8, pp. 1650-1655, 2012.
6. M. Kakinohana, E. Motonaga, T. Saitoh, Y. Taira, and Y. Okuda, "Propofol suppressed electromyographic fibrillation potentials in a patient with amyotrophic lateral sclerosis," Journal of Anesthesia, vol. 13, no. 2, pp. 122-124, 1999.
7. W. Ouyang, G. Wang, and H. C. Hemmings Jr., "Isoflurane and propofol inhibit voltage-gated sodium channels in isolated rat neurohypophysial nerve terminals," Molecular Pharmacology, vol. 64, no. 2, pp. 373-381, 2003.
8. G. Haeseler, N. Foadi, J. Ahrens, R. Dengler, H. Hecker, and M. Leuwer, "Tramadol, fentanyl and sufentanil but not morphine block voltage-operated sodium channels," Pain, vol. 126, no. 1-3, pp. 234-244, 2006.
9. M. C. Bellingham, "Areviewof the neuralmechanisms of action and clinical efficiency of riluzole in treating amyotrophic lateral sclerosis: what have we learned in the last decade" CNS Neuroscience and Therapeutics, vol. 17, no. 1, pp. 4-31, 2011.
10. B. Mohammadi, N. Lang, R. Dengler, and J. Bufler, "Interaction of high concentrations of riluzole with recombinant skeletal muscle sodium channels and adult-type nicotinic receptor channels," Muscle and Nerve, vol. 26, no. 4, pp. 539-545, 2002.
11. E. Palma, M. Inghilleri, L. Conti et al., "Physiological characterization of human muscle acetylcholine receptors from ALS patients," Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 50, pp. 20184-20188, 2011.
12. C. Deflorio, E. Palma, L. Conti et al., "Riluzole blocks human muscle acetylcholine receptors," The Journal of Physiology, vol. 590, no. 10, pp. 2519-2528, 2012.
13. Y.-J. Wang, M.-W. Lin, A.-A. Lin, and S.-N. Wu, "Riluzoleinduced block of voltage-gated Na+ current and activation of BKCa channels in cultured differentiated human skeletalmuscle cells," Life Sciences, vol. 82, no. 1-2, pp. 11-20, 2008.
14. R. G. Miller, J. D. Mitchell, and D. H. Moore, "Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)," Cochrane Database of Systematic Reviews, vol. 3, Article ID CD001447, 2012.
15. R. Kelc, M. Trapecar, M. Vogrin, and A. Cencic, "Skeletal muscle-derived cell cultures as potent models in regenerative medicine research," Muscle and Nerve, vol. 47, no. 4, pp. 477-482, 2013.
16. A. P. Valencia and E. E. Spangenburg, "Remembering those "lazy" days-imprintingmemory in our satellite cells,"TheJournal of Physiology, vol. 591, no. 18, article 4371, 2013.
17. D. Chen, S. Chen, W. Wang et al., "Functional modulation of satellite cells in long-termdenervated human laryngealmuscle," Laryngoscope, vol. 120, no. 2, pp. 353-358, 2010.
18. P.-F. Pradat, A. Barani, J. Wanschitz et al., "Abnormalities of satellite cells function in amyotrophic lateral sclerosis," Amyotrophic Lateral Sclerosis, vol. 12, no. 4, pp. 264-271, 2011.
19. T. Kobayashi, V. Askanas, and W. K. Engel, "Human muscle cultured in monolayer and cocultured with fetal rat spinal cord: importance of dorsal root ganglia for achieving successful functional innervation," The Journal of Neuroscience, vol. 7, no. 10, pp. 3131-3141, 1987.
20. N. Imbert, C. Vandebrouck, G. Duport et al., "Calcium currents and transients in co-cultured contracting normal and Duchenne muscular dystrophy human myotubes," The Journal of Physiology, vol. 534, no. 2, pp. 343-355, 2001.
21. E. Bandi, M. Jevsek, T. Mars et al., "Neural agrin controls maturation of the excitation-contraction coupling mechanism in human myotubes developing in vitro," American Journal of Physiology-Cell Physiology, vol. 294, no. 1, pp. C66-C73, 2008.
22. R. G. Kallen, Z.-H. Sheng, J. Yang, L. Chen, R. B. Bogart, and R. L. Barchi, "Primary structure and expression of a sodium channel characteristic of denervated and immature rat skeletal muscle," Neuron, vol. 4, no. 2, pp. 233-242, 1990.
23. T. Gonoi, S. J. Sherman, and W. A. Catterall, "Voltage clamp analysis of tetrodotoxin-sensitive and-insensitive sodiumchannels in rat muscle cells developing in vitro," Journal of Neuroscience, vol. 5, no. 9, pp. 2559-2564, 1985.
24. R. L. Ruff and D. Whittlesey, "Na+ current densities and voltage dependence in human intercostal muscle fibres," The Journal of Physiology, vol. 458, pp. 85-97, 1992.
25. F. Trombin, V. Gnatkovsky, and M. de Curtis, "Changes in action potential features during focal seizure discharges in the entorhinal cortex of the in vitro isolated guinea pig brain," Journal of Neurophysiology, vol. 106, no. 3, pp. 1411-1423, 2011.
26. J. M. Gregson, M. J. Leathley, A. P. Moore, T. L. Smith, A. K. Sharma, and C. L. Watkins, "Reliability of measurements of muscle tone and muscle power in stroke patients," Age and Ageing, vol. 29, no. 3, pp. 223-228, 2000.
27. G.-L. Jiang, L.-Y. Zhang, L.-Y. Shen, J.-G. Xu, and Y.-D. Gu, "Fibrillation potential amplitude to quantitatively assess denervation muscle atrophy," Neuromuscular Disorders, vol. 10, no. 2, pp. 85-91, 2000.
28. S. Devi, R. E. Lovelace, and N. Duarte, "Proximal peroneal nerve conduction velocity: recording from anterior tibial and peroneus brevis muscles," Annals of Neurology, vol. 2, pp. 116-119, 1977.
29. A. Le Liboux, J.-P. Cachia, S. Kirkesseli et al., "A comparison of the pharmacokinetics and tolerability of riluzole after repeat dose administration in healthy elderly and young volunteers," The Journal of Clinical Pharmacology, vol. 39,no. 5, pp. 480-486, 1999.
30. M. Mestre, Y. Djellas, T. Carriot, and I. Cavero, "Frequencyindependent blockade of cardiac Na+ channels by riluzole: comparison with established anticonvulsants and class I antiarrhythmics," Fundamental and Clinical Pharmacology, vol. 14, no. 2, pp. 107-117, 2000.
31. S. Weiss, D. Benoist, E. White,W. Teng, and D. A. Saint, "Riluzole protects against cardiac ischaemia and reperfusion damage via block of the persistent sodium current," British Journal of Pharmacology, vol. 160, no. 5, pp. 1072-1082, 2010.